InvestorsHub Logo
Followers 49
Posts 2739
Boards Moderated 0
Alias Born 02/06/2017

Re: None

Tuesday, 07/25/2017 8:49:04 PM

Tuesday, July 25, 2017 8:49:04 PM

Post# of 685801
Mesenchymal in Glioblastoma is HUGE as a % ~ 48%

And not some MINOR subgroup .....

Moreover - Mesenchymal + Classical ~ 73% of Glioblastoma
and there is no reason to suspect that DCVax-L is not superior to
SOC in the Classical subtype .....

We will all find out soon enought ......

Mesenchymal

Source

MES

FYI

Concepts

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News